Erasca Target Price

Analysts' average 12-month price target for Erasca is $23.

Get informed when a big investor buys or sells

+ Follow

Share Price

$18.1

Average Target Price

$22.50

24.3% upside

8 analysts in the last 4 months

High: $30 | Low: $16

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-13	GuggenheimMichael Schmidt	$21	16% upside
2026-08-12	H.C. Wainwright	$22	21.5% upside
2026-07-20	Morgan Stanley	$21	16% upside
2026-07-14	Jefferies	$24	32.6% upside
2026-07-14	HSBC	$20	10.5% upside
2026-06-04	Wolfe Research	$16	11.6% downside
2026-05-12	Mizuho Securities	$26	43.6% upside
2026-04-27	Stifel Nicolaus	$30	65.7% upside
2026-03-10	Stifel NicolausLaura Prendergast	$20	10.5% upside
2026-01-27	Guggenheim	$12	33.7% downside
2026-01-26	Morgan StanleySean Laaman	$10	44.8% downside
2026-01-16	Piper Sandler	$11	39.2% downside
2026-01-12	Stifel NicolausLaura Prendergast	$10	44.8% downside
2026-01-08	Morgan Stanley	$4	77.9% downside
2026-01-07	Piper Sandler	$5	72.4% downside
2025-12-09	Mizuho Securities	$5	72.4% downside
2025-11-06	Stifel Nicolaus	$6	66.9% downside
2025-10-15	Stifel NicolausLaura Prendergast	$4	77.9% downside
2025-05-14	GuggenheimMichael Schmidt	$3	83.4% downside
2025-03-26	Raymond JamesLaura Prendergast	$5	72.4% downside
2024-11-18	JefferiesMaury Raycroft	$6	66.9% downside
2024-04-01	Goldman SachsChris Shibutani	$7	61.3% downside

Erasca (ERAS) FAQ

Erasca posts a target price of $23. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $23 for ERAS means covering analysts, on average, see the stock 24.3% upside of $18.1 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for ERAS's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Erasca's other metric pages and overview cover the third.

Judging Erasca against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $23 here, then scan peer and history charts to see if the gap is persistent.